Borealis Foods Hit With Second Nasdaq Deficiency Notice Over Delayed 10-Q
BRLS sits 90% above its 52-week low of $0.6.
Summary
Borealis Foods received a second Nasdaq deficiency notice for failing to file its Q2-2026 10-Q on time, adding to an existing delisting notice for market value non-compliance. The company has until October 26, 2026 to submit a compliance plan.
Key Events · Legal and Risk Events · BRLS
-
Second Nasdaq Deficiency Notice
Received August 26, 2026 for failure to file Q2-2026 Form 10-Q, violating Listing Rule 5250(c)(1). This is separate from the July 8 delisting notice for market value non-compliance.
-
Compliance Deadlines
Company must submit a compliance plan by October 26, 2026. If accepted, Nasdaq may grant up to 180 days from the 10-Q due date, extending the deadline to February 16, 2027.
-
Filing Delay Cause
The 10-Q was delayed by an ongoing review with independent auditors of the accounting treatment for the previously disclosed Conversion Agreement, which requires shareholder approval under Nasdaq rules.
-
Compounding Listing Risk
This is the second active Nasdaq compliance issue. The company already faces delisting for failing the $35 million minimum market value requirement, with the stock at $1.14 and market cap near $24 million.
Analysis · BRLS · Manufacturing
A new Nasdaq deficiency notice landed on August 26, 2026, this time for failing to file the Q2-2026 Form 10-Q on time. It marks the second listing compliance issue in under two months—the company already faces a delisting notice from July 8 for missing the $35 million minimum market value requirement. The company has until October 26, 2026 to submit a compliance plan, and if accepted, could get until February 16, 2027 to regain compliance. The filing delay stems from an ongoing review with auditors of the accounting treatment for a previously disclosed Conversion Agreement, which itself is subject to shareholder approval under Nasdaq rules. With the stock at $1.14 and a market cap near $24 million, the company is already below the market value threshold, making this second deficiency a compounding threat to its Nasdaq listing.
How filings like this one have moved
In the 30 days to Sep 11, 2026, 36.1% of the 1753 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.04%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BRLS was trading at $1.14 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $24.5M. The 52-week trading range was $0.60 to $5.02. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.